Institut Mérieux is a French

holding company A holding company is a company whose primary business is holding a controlling interest in the securities of other companies. A holding company usually does not produce goods or services itself. Its purpose is to own shares of other companies ...

owned by the Mérieux family from

Lyon Lyon,, ; Occitan: ''Lion'', hist. ''Lionés'' also spelled in English as Lyons, is the third-largest city and second-largest metropolitan area of France. It is located at the confluence of the rivers Rhône and Saône, to the northwest of t ...

History

It was created by

Marcel Mérieux Marcel may refer to: People * Marcel (given name), people with the given name Marcel * Marcel (footballer, born August 1981), Marcel Silva Andrade, Brazilian midfielder * Marcel (footballer, born November 1981), Marcel Augusto Ortolan, Brazilian s ...

in 1897 under the name ''Institut Biologique Mérieux'' (Mérieux Biological Institute). The

vaccine A vaccine is a biological Dosage form, preparation that provides active acquired immunity to a particular infectious disease, infectious or cancer, malignant disease. The safety and effectiveness of vaccines has been widely studied and verifie ...

development branch of the institute was separated early on and is now part of

Sanofi Pasteur Sanofi Pasteur is the vaccines division of the French multinational pharmaceutical company Sanofi. Sanofi Pasteur is the largest company in the world devoted entirely to vaccines. It is one of four global producers of the yellow fever vaccine. ...

.^,^, The current name was changed in 2009 from Mérieux Alliance. The holding is owned through the Mérieux Alliance company at 68% by Alain and Alexandre Mérieux and at 32% by the Christophe and Rodolphe Mérieux foundation (different from the Mérieux foundation). Alongside diagnostic activities, Alain Mérieux develops new complementary bio-industrial activities. The holding company then took in 1994, the control of Transgene, specialized in gene therapy, then of Silliker (specialized in food security),. in 1998. In 2001, Biomérieux acquired the diagnostic company Organon Teknika. Its Advanced Bioscience Laboratories Inc. sector, a contract research company, is then bought by the Mérieux family holding company. In 2010, the institute structured its nutrition and health division around Silliker and Biofortis under the name of Mérieux NutriSciences. In January 2020, Institut Mérieux co-founded the Hub VPH, the first global hub in veterinary public health, whose objective is to catalyze the driving forces of research, innovation, education and industry in the Auvergne-Rhône-Alpes region around this activity.

Holding

Through creations and acquisitions, the holding is managing the following companies:^,^, *

BioMérieux bioMérieux SA is a French multinational biotechnology company founded and headquartered in Marcy-l'Étoile, France, close to Lyon. bioMérieux is present in 44 countries and serves more than 160 countries through a large network of distributors ...

, created by Alain Mérieux in 1963, owned at 59% * Mérieux NutriSciences, renamed from the acquired

Chicago (''City in a Garden''); I Will , image_map = , map_caption = Interactive Map of Chicago , coordinates = , coordinates_footnotes = , subdivision_type = Country , subdivision_name ...

-based company Silliker, and encompassing the Biofortis and Bioagri companies, owned at 70% by the holding *

Transgene A transgene is a gene that has been transferred naturally, or by any of a number of genetic engineering techniques, from one organism to another. The introduction of a transgene, in a process known as transgenesis, has the potential to change the ...

"designs and develops therapeutic vaccines and immunotherapy products to treat cancers and infectious diseases" and is owned at 55% by the holding * Advanced BioScience Laboratories, Inc, an unlisted company dedicated to

research and development Research and development (R&D or R+D), known in Europe as research and technological development (RTD), is the set of innovative activities undertaken by corporations or governments in developing new services or products, and improving existi ...

infectious diseases An infection is the invasion of tissues by pathogens, their multiplication, and the reaction of host tissues to the infectious agent and the toxins they produce. An infectious disease, also known as a transmissible disease or communicable dise ...

AIDS Human immunodeficiency virus infection and acquired immunodeficiency syndrome (HIV/AIDS) is a spectrum of conditions caused by infection with the human immunodeficiency virus (HIV), a retrovirus. Following initial infection an individual m ...

in particular; owned entirely by the holding * Mérieux Développement * IMAccess a not for profit company dedicated to the development, production and supply of rapid diagnostic tests to

developing countries A developing country is a sovereign state with a lesser developed industrial base and a lower Human Development Index (HDI) relative to other countries. However, this definition is not universally agreed upon. There is also no clear agreem ...

, owned entirely by the holding

References

External links

History page
on the Fondation Mérieux website {{DEFAULTSORT:Merieux Institute Holding companies of France Medical technology companies of France